Marshall Wace’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Marshall Wace’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-425,490	Closed	-$4.44M	–	3193
2023 Q1	$4.44M	Hold	425,490	–	–	0.01%	1057
2022 Q4	$4.37M	Hold	425,490	–	–	0.01%	1273
2022 Q3	$4.28M	Buy	425,490 +368,837	+651%	+$3.7M	0.01%	1485
2022 Q2	$563K	Buy	56,653 +112	+0.2%	+$1.12K	﹤0.01%	2735
2022 Q1	$563K	Buy	+56,541	New	+$561K	﹤0.01%	2723

Marshall Wace's LVAC Position: Q2 2023 in Review

Marshall Wace sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 425,490 shares — an estimated $4.44M sold.

Marshall Wace first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $4.44M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Marshall Wace reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Marshall Wace sold 425,490 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $4.44M.
Marshall Wace first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Marshall Wace's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $4.44M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.